Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-049432
Filing Date
2024-12-10
Accepted
2024-12-10 14:04:35
Documents
1
Period of Report
2024-11-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3369
  Complete submission text file 0001493152-24-049432.txt   5295
Mailing Address 280 SOUTH BEVERLY DR. SUITE 505 BEVERLY HILLS CA 90212
Business Address 280 SOUTH BEVERLY DR. SUITE 505 BEVERLY HILLS CA 90212 508-523-3141
Nordicus Partners Corp (Issuer) CIK: 0001011060 (see all company filings)

EIN.: 043186647 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)

Mailing Address MESTERLODDEN 3A, 1. GENTOFTE G7 2820
Business Address MESTERLODDEN 3A, 1. GENTOFTE G7 2820 4553842743
Alteral Therapeutics ApS (Reporting) CIK: 0002026040 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-11737 | Film No.: 241537980